Table I.
Summary of studies showing impaired or defective expression of interferon mRNA or protein in cells from asthmatic patients
Reference | Cell type | Phenotype of asthma and age | Interferons studied | Evidence | Main findings |
---|---|---|---|---|---|
Bufe et al4 | PBMCs | Atopic asthmatic children | IFN-α | ∗, † | First report of impaired interferon using NDV |
Wark et al5 | HBECs | Mild atopic asthmatic adults | IFN-β | ∗, ‡, §, ‖ | Associated with apoptosis and not steroid dependent |
Contoli et al6 | HBECs/BAL cells | Mild atopic asthmatic adults | IFN-λs | ∗, † | Associated with clinical end points after experimental rhinovirus challenge |
Gehlhar et al32 | PBMCs | Atopic asthmatic adults | IFN-α | ∗ | RSV and NDV |
Sykes et al30 | BAL cells | Mild-to-moderate atopic asthmatic patients | IFN-α, IFN-β | ∗, † | No impairment of critical signaling molecules, related to atopy |
Edwards et al36 | HBECs | STRA atopic asthmatic children | IFN-β, IFN-λs | ∗, ‡, ‖ | Interferon mRNA impaired to rhinovirus and poly I:C |
Uller et al35 | HBECs | Mostly atopic, mixed asthma severity, adults | IFN-β | ∗, ‖ | TSLP levels greater in asthmatic group |
Wark et al44 | HBECs | Mild persistent atopic asthmatic patients | IFN-β | ∗ | IFN-β protein studied only |
Gill et al28 | Blood pDCs | Atopic asthmatic adults and children | IFN-α | ∗, ‖ | Influenza virus, related to IgE |
Iikura et al47 | PBMCs | Atopic mild-to-moderate asthmatic adults and children | IFN-α | ∗ | Impaired IFN-α in children only also impaired proinflammatory cytokine |
Durrani et al29 | Blood pDCs | Atopic asthmatic children | IFN-α, IFN-λs | ∗ | Rhinovirus, related to asthma not atopy |
Baraldo et al34 | HBECs | Atopic and nonatopic asthmatic children | IFN-β, IFN-λs | ∗, †, ‡ | Associated with increased IL-4 staining, eosinophilia, and IgE in atopic subjects |
Wagener et al46 | NECs/HBECs | Atopic asthmatic patients | IFN-β, IFN-λs | ∗ | Poly I:C IFN-β and IL-28 mRNA expression in asthmatic patients by microarray |
Collison et al50 | HBECs | Persistent asthmatic adults | IFN-λs | ∗ | No difference in intracellular viral RNA |
Spann et al45 | NECs/TECs | Atopic children with wheeze | IFN-β, IFN-λs | ∗ | Impaired IFN-β only in NECs with RSV |
Hatchwell et al49 | Bronchial biopsy specimens | Patients with moderate-to-severe eosinophilic asthma | IFN-α/β, IFN-λs | ∗ | Impaired IL-28 related to impaired TLR7 |
Rupani et al31 | AMs | Severe nonatopic asthma | IFN-α, IFN-β | ∗ | Identification of mir-150, 152, and 375 as associated with impaired interferons |
Kicic et al33 | HBECs | Atopic asthmatic children | IFN-β | ∗, ‡, §, ‖ | Related to defective wound repair |
Teach et al51 | PBMCs | Atopic asthmatic children | IFN-α | ∗, † | Restored by anti-IgE therapy |
Lin et al48 | PBMCs | Atopic asthmatic children | IFN-α, IFN-β | ∗, ‖ | Impaired interferon group identified by using cluster analysis had higher rates of asthma. |
BAL, Bronchoalveolar lavage; NDV, Newcastle disease virus; NECs, nasal epithelial cells; pDCs, plasmacytoid dendritic cells; STRA, severe therapy-resistant asthma; TEC, tracheal epithelial cell; TSLP, thymic stromal lymphopoietin.
Level of evidence:
Interferon levels in asthmatic donors were significantly lower than those of control subjects.
Deficient interferon levels were related to clinical disease, such as number of AEs, eosinophilia, lung function, IgE levels, atopy, and TH2 markers.
Significantly higher viral loads in asthmatic patients or significantly lower interferon levels that were negatively correlated with higher viral loads in asthmatic patients.
Exogenous IFN-β restored the antiviral response.
Other noninterferon cytokines were not significantly different between asthmatic donors and control subjects.